Suppressibility of thyroid function during treatment with antithyroid drugs in Grave's disease.
D013956:Antithyroid Agents / Q000627:therapeutic use*; D003864:Depression, Chemical; D006111:Graves Disease / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007455:Iodine / Q000378:metabolism*; D007457:Iodine Radioisotopes; D008713:Methimazole / Q000627:therapeutic use; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000187:drug effects / Q000503:physiopathology*; D013972:Thyrotropin / Q000378:metabolism; D013974:Thyroxine; D013997:Time Factors; D014284:Triiodothyronine
D013956:Antithyroid Agents; D007093:Imidazoles; D007457:Iodine Radioisotopes; D014284:Triiodothyronine; D008713:Methimazole; D013972:Thyrotropin; D007455:Iodine; D013974:Thyroxine